Cargando…
Immunotherapy of acute myeloid leukemia based on γδ T cells
A current major challenge of acute myeloid leukemia research is to develop immunotherapeutic strategies that would be employable in all patients. We recently reported that appropriately stimulated γδ T cells are fully capable of mediating cytotoxicity against leukemic blasts.
Autores principales: | Gertner-Dardenne, Julie, Fauriat, Cyril, Vey, Norbert, Olive, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3525621/ https://www.ncbi.nlm.nih.gov/pubmed/23264912 http://dx.doi.org/10.4161/onci.21512 |
Ejemplares similares
-
BTLA, a key regulator of Vγ9Vδ2 T-cell proliferation
por: Gertner-Dardenne, Julie, et al.
Publicado: (2013) -
Multifunctional γδ T cells and their receptors for targeted anticancer immunotherapy
por: Scheper, Wouter, et al.
Publicado: (2013) -
Combining conventional chemotherapy and γδ T cell-based immunotherapy to target cancer-initiating cells
por: Todaro, Matilde, et al.
Publicado: (2013) -
Peripheral T-cell tolerance in hosts with acute myeloid leukemia
por: Chen, Xiufen, et al.
Publicado: (2013) -
Increased NK Cell Maturation in Patients with Acute Myeloid Leukemia
por: Chretien, Anne-Sophie, et al.
Publicado: (2015)